We came across a bullish thesis on Achieve Life Sciences, Inc. (ACHV) on Substack by Jacob Rowe. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc. (ACHV)’s share was trading at $3 as of Jan 23rd.
Copyright: nedoba / 123RF Stock Photo
Achieve Life Sciences (ACHV) presents a compelling investment opportunity, with its nicotine cessation drug, Cytisinicline, positioned to disrupt the market. The company has reached a significant milestone in its...
